Liver International

Cover image for Vol. 31 Issue 4

April 2011

Volume 31, Issue 4

Pages 437–588

  1. Editorials

    1. Top of page
    2. Editorials
    3. Review Articles
    4. Clinical Studies
    5. Liver International Image
    6. Basic Studies
    7. Letters to the Editor
    8. Corrigenda
    1. You have free access to this content
    2. You have free access to this content
  2. Review Articles

    1. Top of page
    2. Editorials
    3. Review Articles
    4. Clinical Studies
    5. Liver International Image
    6. Basic Studies
    7. Letters to the Editor
    8. Corrigenda
    1. You have free access to this content
      Genes and hepatitis C: susceptibility, fibrosis progression and response to treatment (pages 443–460)

      Manuel Romero-Gomez, Mohamed Eslam, Agustín Ruiz and Marta Maraver

      Version of Record online: 30 JAN 2011 | DOI: 10.1111/j.1478-3231.2011.02449.x

    2. You have free access to this content
      Systematic review of performance of non-invasive biomarkers in the evaluation of non-alcoholic fatty liver disease (pages 461–473)

      Michael H. Miller, Michael A. J. Ferguson and John F. Dillon

      Version of Record online: 1 FEB 2011 | DOI: 10.1111/j.1478-3231.2011.02451.x

  3. Clinical Studies

    1. Top of page
    2. Editorials
    3. Review Articles
    4. Clinical Studies
    5. Liver International Image
    6. Basic Studies
    7. Letters to the Editor
    8. Corrigenda
    1. Clinical significance and potential of hepatic microRNA-122 expression in hepatitis C (pages 474–484)

      Kazutoyo Morita, Akinobu Taketomi, Ken Shirabe, Kenji Umeda, Hiroto Kayashima, Mizuki Ninomiya, Hideaki Uchiyama, Yuji Soejima and Yoshihiko Maehara

      Version of Record online: 30 DEC 2010 | DOI: 10.1111/j.1478-3231.2010.02433.x

    2. Predictive factors for long-term survival in patients with clinically significant portal hypertension following resection of hepatocellular carcinoma (pages 485–493)

      Gi H. Choi, Jun Y. Park, Ho K. Hwang, Dong H. Kim, Chang M. Kang, Jin S. Choi, Young N. Park, Do Y. Kim, Sang H. Ahn, Kwang-Hyub Han, Chae Y. Chon and Woo J. Lee

      Version of Record online: 15 FEB 2011 | DOI: 10.1111/j.1478-3231.2010.02436.x

    3. Detection of bacterial DNA in serum and ascitic fluid of asymptomatic outpatients with cirrhosis and non-neutrocytic ascites (pages 494–498)

      Thomas Sersté, Frédéric Bert, Véronique Leflon-Guibout, Chantal Chauvet, Estelle Marcon, Tarik Asselah, Claire Francoz, François Durand, Didier Lebrec, Dominique Valla, Richard Moreau and Marie-Hélène Nicolas-Chanoine

      Version of Record online: 30 JAN 2011 | DOI: 10.1111/j.1478-3231.2011.02448.x

    4. Lamivudine treatment is associated with improved survival in fulminant hepatitis B (pages 499–506)

      Jian-Wu Yu, Li-Jie Sun, Bing-Zhu Yan, Peng Kang and Yong-Hua Zhao

      Version of Record online: 30 JAN 2011 | DOI: 10.1111/j.1478-3231.2011.02450.x

    5. Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection (pages 507–515)

      Salvatore Petta, Calogero Cammà, Vito Di Marco, Fabio Salvatore Macaluso, Marcello Maida, Giuseppe Pizzolanti, Beatrice Belmonte, Daniela Cabibi, Rosa Di Stefano, Donatella Ferraro, Carla Guarnotta, Giovanna Venezia and Antonio Craxì

      Version of Record online: 30 JAN 2011 | DOI: 10.1111/j.1478-3231.2011.02453.x

    6. Adherence to treatment and quality of life during hepatitis C therapy: a prospective, real-life, observational study (pages 516–524)

      Patrick Marcellin, Michel Chousterman, Thierry Fontanges, Denis Ouzan, Michel Rotily, Marina Varastet, Jean-Philippe Lang, Pascal Melin, Patrice Cacoub and for the CheObs Study Group

      Version of Record online: 15 FEB 2011 | DOI: 10.1111/j.1478-3231.2011.02461.x

    7. Gas exchanges and pulmonary vascular abnormalities at different stages of chronic liver disease (pages 525–533)

      Simone Scarlata, Maria E. Conte, Matteo Cesari, Umberto V. Gentilucci, Lucia Miglioresi, Claudio Pedone, Antonio Picardi, Giovanni L. Ricci and Raffaele A. Incalzi

      Version of Record online: 15 FEB 2011 | DOI: 10.1111/j.1478-3231.2011.02467.x

    8. Resting myocardial dysfunction in cirrhosis quantified by tissue Doppler imaging (pages 534–540)

      Konstantin Kazankov, Peter Holland-Fischer, Niels H. Andersen, Peter Torp, Erik Sloth, Niels K. Aagaard and Hendrik Vilstrup

      Version of Record online: 15 FEB 2011 | DOI: 10.1111/j.1478-3231.2011.02468.x

  4. Liver International Image

    1. Top of page
    2. Editorials
    3. Review Articles
    4. Clinical Studies
    5. Liver International Image
    6. Basic Studies
    7. Letters to the Editor
    8. Corrigenda
    1. Pedunculated hepatic mass (page 541)

      Ho Sung Park, Young Kon Kim, Baik Hwan Cho and Woo Sung Moon

      Version of Record online: 25 AUG 2010 | DOI: 10.1111/j.1478-3231.2010.02318.x

  5. Basic Studies

    1. Top of page
    2. Editorials
    3. Review Articles
    4. Clinical Studies
    5. Liver International Image
    6. Basic Studies
    7. Letters to the Editor
    8. Corrigenda
    1. A novel and comprehensive mouse model of human non-alcoholic steatohepatitis with the full range of dysmetabolic and histological abnormalities induced by gold thioglucose and a high-fat diet (pages 542–551)

      Mitsunari Ogasawara, Akira Hirose, Masafumi Ono, Kosuke Aritake, Yasuko Nozaki, Masaya Takahashi, Nobuto Okamoto, Shuji Sakamoto, Shinji Iwasaki, Taketoshi Asanuma, Taketoshi Taniguchi, Yoshihiro Urade, Saburo Onishi, Toshiji Saibara and Jude A Oben

      Version of Record online: 19 JAN 2011 | DOI: 10.1111/j.1478-3231.2010.02443.x

    2. A glycyrrhizin-containing preparation reduces hepatic steatosis induced by hepatitis C virus protein and iron in mice (pages 552–560)

      Masaaki Korenaga, Isao Hidaka, Sohji Nishina, Aya Sakai, Akane Shinozaki, Toshikazu Gondo, Takakazu Furutani, Hiroo Kawano, Isao Sakaida and Keisuke Hino

      Version of Record online: 15 FEB 2011 | DOI: 10.1111/j.1478-3231.2011.02469.x

    3. Aflatoxin genotoxicity is associated with a defective DNA damage response bypassing p53 activation (pages 561–571)

      Ozge Gursoy-Yuzugullu, Haluk Yuzugullu, Mustafa Yilmaz and Mehmet Ozturk

      Version of Record online: 15 FEB 2011 | DOI: 10.1111/j.1478-3231.2011.02474.x

    4. Transforming growth factor-α attenuates hepatic fibrosis: possible involvement of matrix metalloproteinase-1 (pages 572–584)

      Tatsuya Ohyama, Yuichi Yamazaki, Ken Sato, Norio Horiguchi, Takeshi Ichikawa, Satoru Kakizaki, Hitoshi Takagi and Masatomo Mori

      Version of Record online: 15 FEB 2011 | DOI: 10.1111/j.1478-3231.2011.02475.x

  6. Letters to the Editor

    1. Top of page
    2. Editorials
    3. Review Articles
    4. Clinical Studies
    5. Liver International Image
    6. Basic Studies
    7. Letters to the Editor
    8. Corrigenda
    1. An unusual trigger for a neurogenic left ventricular dysfunction: Tako–Tsubo syndrome associated with hepatic encephalopathy (pages 585–586)

      Aurélien Seemann, Nadège Demars, Stéphane Manzo-Silberman, Alain Cariou and Jérôme Fichet

      Version of Record online: 30 DEC 2010 | DOI: 10.1111/j.1478-3231.2010.02429.x

    2. A pilot study of vitamin E for the treatment of cirrhotic muscle cramps (pages 586–587)

      Natasha Chandok, Patrick Tan, Julia Uhanova, Neil Shankar and Paul Marotta

      Version of Record online: 1 FEB 2011 | DOI: 10.1111/j.1478-3231.2011.02464.x

  7. Corrigenda

    1. Top of page
    2. Editorials
    3. Review Articles
    4. Clinical Studies
    5. Liver International Image
    6. Basic Studies
    7. Letters to the Editor
    8. Corrigenda
    1. You have free access to this content
      CORRIGENDA (page 588)

      Version of Record online: 1 FEB 2011 | DOI: 10.1111/j.1478-3231.2011.02478.x

      This article corrects:
    2. You have free access to this content

SEARCH

SEARCH BY CITATION